M&A / Deals RoosterBio and MineBio team up to expand MSC solutions access in China Pharmaceutical Business ReviewMineBio will supply RoosterBio's complete platform of products, having already obtained import clearance.M&A / DealsRead full story pharminent April 8, 2026 (Last updated: April 8, 2026) Pharmaceutical Business Review MineBio will supply RoosterBio’s complete platform of products, having already obtained import clearance. M&A / DealsRead full story Post navigation Previous: Halozyme and Vertex sign deal for Hypercon technologyNext: EU invests 30m to fight antimicrobial resistance Related Stories M&A / Deals Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B pharminent May 13, 2026 M&A / Deals BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal pharminent May 12, 2026 M&A / Deals Cellular Intelligence scoops up Novo’s Parkinson’s therapy pharminent May 12, 2026
